Predoctoral Researcher Extension - Immunity, Inflammation, and Cancer

Ref.: 24-052_R_CS

About the research group

Soler’s group is part of the Immunity, Inflammation, and Cancer group within the Oncobell Program, as well as the Immunology Unit in the Department of Pathology and Experimental Therapies at Universitat de Barcelona.

Our research focuses on understanding the mechanisms, functions, and dysfunctions of TREX2, a keratinocyte-specific exonuclease implicated in skin homeostasis, cancer, and inflammatory skin diseases like psoriasis. Through our studies, we have identified TREX2 as a promising target for innovative keratinocyte-based therapies.

About the role

We are seeking a highly motivated predoctoral researcher with strong technical skills and a multidisciplinary background who will be just a few months away from completing their PhD at the end of October.

Job requirements

Professional experience

• At least 3 years of experience conducting a PhD in the Bellvitge campus
• Experience with models of skin inflammatory diseases
• Experience with biochemical and biophysical assays
• Experience with keratinocyte tissue culture

Education and training

• Bachelor's in Biomedical Sciences
• Master's degree in Biomedical Sciences

Soft skills

• Self-organization and initiative

Languages

• Good command of the English language
  

What do we offer

• No. of positions: 1

• Estimated start date: 01/11/2024

• Contract duration: 2 months

• Estimated annual gross salary: 23.872 €
  
  
• You will be part of a multicultural team. We have a fun loving and friendly international work environment.

• Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
  
  

• Possibility to work some days in remote - Teleworking

• 26 working days of holiday per year

• System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.

• Paid leave package

• Benefits of constant training are offered

• We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
  

Deadline: Please submit your application by 21/05/2024

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate.

You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).